Physician Assistant, Medical · Chicopee, MA
NPI
1750949509
Since 2019
Specialty
Physician Assistant, Medical
Code 363AM0700X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
444 Montgomery St
Chicopee, MA, 01020
Phone (413) 594-3111
Groups this clinician bills Medicare through
Medicare paid, 2024
$47K
755 services
Medicare patients, 2024
330
Average age 70
Drug cost, 2024
$2.2M
5,154 prescriptions
Company payments, 2025
$161
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nisha R Malik was code 99214 (office e&m - established), 489 times for 283 patients. In total Nisha R Malik billed 755 services in 11 codes, and Medicare paid $47K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-06-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 489 | 283 | $75.10 | $37K |
| 99213 Office E&M - Established | Office | 145 | 118 | $50.11 | $7,265 |
| 95251 Test - Miscellaneous | Office | 93 | 48 | $21.60 | $2,009 |
By year: 2022 $46K for 603 services; 2023 $52K for 863 services; 2024 $47K for 755 services.
Medicare prescription drug claims, 2024
In 2024, the drug Nisha R Malik prescribed most often to Medicare patients was Trulicity (Dulaglutide), with 570 prescriptions and refills. In total Nisha R Malik wrote 5,154 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trulicity Dulaglutide | 570 | 673 | 124 | $651K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 545 | 1,161 | 163 | $83K |
| Ozempic Semaglutide | 409 | 448 | 82 | $404K |
| Levothyroxine Sodium Generic | 325 | 682 | 95 | $3,322 |
| Jardiance Empagliflozin | 308 | 447 | 68 | $263K |
| Metformin Hcl Er Metformin Hcl | 286 | 638 | 86 | $4,386 |
| Novolog Flexpen Insulin Aspart | 236 | 354 | 72 | $60K |
| Humalog Kwikpen U-100 Insulin Lispro | 219 | 382 | 77 | $62K |
| Metformin Hcl Generic | 215 | 538 | 78 | $2,413 |
| Ultra-Fine Short Pen Needle Pen Needle, Diabetic | 191 | 456 | 76 | $21K |
| Glipizide Generic | 178 | 427 | 61 | $2,232 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 135 | 304 | 54 | $15K |
| Methimazole Generic | 109 | 189 | 27 | $1,034 |
| Basaglar Kwikpen U-100 Insulin Glargine,hum.Rec.Anlog | 109 | 259 | 41 | $62K |
| Alendronate Sodium Generic | 103 | 185 | 30 | $1,224 |
Brand drugs: 3,223 claims; generic drugs: 1,314 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nisha R Malik $161 ($161 in general payments such as food, travel and fees) from 1 company. The largest payer was Abbott Laboratories with $161.
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories ABT | 9 | $161 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.